Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04KVQ
|
|||
| Former ID |
DIB006461
|
|||
| Drug Name |
BAY-86-9596
|
|||
| Synonyms |
D-FMT; D-18F-fluoromethyl tyrosine; D-fluoromethyl tyrosine-[18F]; Diagnostic 18F-labeled PET tracer, Bayer; 18-F PET tracer (diagnostic imaging), Bayer; 18F-labeled PET imaging agent (cancer), Bayer Schering Pharma
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Bayer AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H12FNO3
|
|||
| Canonical SMILES |
C1=CC(=CC=C1CC(C(=O)O)N)OCF
|
|||
| InChI |
1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1
|
|||
| InChIKey |
GEBHVOHKNWLITQ-DEVVULMSSA-N
|
|||
| CAS Number |
CAS 870452-26-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01089998) PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.